1e
19
1
49
2
2
18
1b
1d
18
37
5b
1d
2 29
1d
25
Deborah Ann Sesok-Pizzini
88
5b
Adjunct Professor of Pathology and Laboratory Medicine
7
78
Department: Pathology and Laboratory Medicine
4
1
b
1d
46
Contact information
57
4
3
3
3
2
4
b
1f
57
260 Barwynne Lane
WYNNEWOOD, PA 19096
26
WYNNEWOOD, PA 19096
2c
Office: 2676631431
30
8d
30
Email:
pizzini@email.chop.edu
12
pizzini@email.chop.edu
13
Education:
21 5 c
38 Dickinson College, Moscow, USSR, 1988.
21 7 BA 14 (Biology) c
45 Franklin and Marshall College, Lancaster, PA, 1989.
21 5 15 (Medicine) c
5b UMDNJ-Robert Wood Johnson Medical School at Camden, Piscataway, NJ, 1992.
21 7 MD c
57 Pennsylvania State University College of Medicine, Hershey, PA, 1994.
21 b M.B.A. 22 (Finance Concentration) c
49 MBA Program, Villanova University, Villanova, PA, 2003.
c
3
3
3
3
8a
Permanent link21 5 c
38 Dickinson College, Moscow, USSR, 1988.
21 7 BA 14 (Biology) c
45 Franklin and Marshall College, Lancaster, PA, 1989.
21 5 15 (Medicine) c
5b UMDNJ-Robert Wood Johnson Medical School at Camden, Piscataway, NJ, 1992.
21 7 MD c
57 Pennsylvania State University College of Medicine, Hershey, PA, 1994.
21 b M.B.A. 22 (Finance Concentration) c
49 MBA Program, Villanova University, Villanova, PA, 2003.
c
2 29
21
1e
1d
24
5e
65
62
e 29
27
Description of Research Expertise
93 HLA antibodies and platelet refractoriness, regulatory/quality blood bank issues, patient safety, stem cell collection and storage.65
Description of Clinical Expertise
dc Blood Bank and Transfusion Medicine, Pediatric Transfusion Medicine, Stem Cell Collection/Processing, HLA, Platelet Refractoriness, Therapeutic Apheresis, Transfusion Support for Solid-Organ Transplants.62
Description of Other Expertise
39 Quality Management/Operational Managemente 29
23
86 Sesok-Pizzini D and Disbot M: Failure Mode and Effects Analysis (FMEA)in Healthcare b0 American Society of Clinical Pathologists Check Sample: Transfusion Medicine. Susan Roseff (eds.). ASCP Press,(TM 06-1 (TM-285)), 1-13, January 2006.
1f2 Gupta S, Tran N, Topolsky D, Sesok-Pizzini D, Crilley P, Balasubramanium M, Kahn SB, Brodsky I and Styler M.: Thrombotic thrombocytopenic purpura induced by cyclosporine A after allogeneic bone marrow transplantation treated by red blood cell exchange transfusion: a case report. American Journal of Hematology. Carlo Brugnara (eds.). Wiley-Liss, Inc. 80(3): 246-247, November 2005 Notes: Accepted as a letter to the editor.
145 Park J, Shelat SG, Crivaro A, Jespersen D, McCarthy T, Xiong Q, Sesok-Pizzini D, Moore J. : Flow cytometric analysis of fetomaternal hemorrhage in the setting of sickle cell disease. Archives of Pathology and Laboratory Medicine Page: 567, April 2005.
eb Sesok-Pizzini, D: Cellular Therapy. Blood Transfusion Therapy, A Physician's Handbook, 8th Edition. Triulzi, DJ (eds.). American Association of Blood Banks, 2004.
e1 Sesok-Pizzini, D: College of American Pathologists Gallup Study Findings on Colon Cancer. Radio Interview. College of American Pathologists, March 2005.
ff Whitney-Miller C and Sesok-Pizzini D.: Evaluation of platelet refractoriness at a large transfusion service. Archives of Pathology and Laboratory Medicine 129: 568-569, April 2005.
ac Sesok-Pizzini, D: Bike Helmet Safety. Radio Interview. College of American Pathologists, June 2005.
177 Sesok-Pizzini, DA: Approaches to Managing Quality and Patient Safety. Quality Management in Clinical Laboratories, Promoting Patient Safety Through Risk Reduction and Continuous Improvement. Paul Valenstein (eds.). College of American Pathologists, Page: 38-40, 2005 Notes: Contributing chapter author.
10c Sesok-Pizzini, D: Immunological Effects of ABO-Incompatible HPC Transplantation. Cellular Therapy: A Physician's Handbook. Hakey NR, Snyder EL, Triulzi D (eds.). AABB Press, Page: 180-185, 2004.
2c
7
1d
1f
Selected Publications
115 Sesok-Pizzini D: Patient Safety Scenario-Based Approach to Communications Training in the Patient Safety Competency-Model. SoftAssist and UPHS (eds.). SoftAssist and UPHS, 2005 Notes: Content Contributor.86 Sesok-Pizzini D and Disbot M: Failure Mode and Effects Analysis (FMEA)in Healthcare b0 American Society of Clinical Pathologists Check Sample: Transfusion Medicine. Susan Roseff (eds.). ASCP Press,(TM 06-1 (TM-285)), 1-13, January 2006.
1f2 Gupta S, Tran N, Topolsky D, Sesok-Pizzini D, Crilley P, Balasubramanium M, Kahn SB, Brodsky I and Styler M.: Thrombotic thrombocytopenic purpura induced by cyclosporine A after allogeneic bone marrow transplantation treated by red blood cell exchange transfusion: a case report. American Journal of Hematology. Carlo Brugnara (eds.). Wiley-Liss, Inc. 80(3): 246-247, November 2005 Notes: Accepted as a letter to the editor.
145 Park J, Shelat SG, Crivaro A, Jespersen D, McCarthy T, Xiong Q, Sesok-Pizzini D, Moore J. : Flow cytometric analysis of fetomaternal hemorrhage in the setting of sickle cell disease. Archives of Pathology and Laboratory Medicine Page: 567, April 2005.
eb Sesok-Pizzini, D: Cellular Therapy. Blood Transfusion Therapy, A Physician's Handbook, 8th Edition. Triulzi, DJ (eds.). American Association of Blood Banks, 2004.
e1 Sesok-Pizzini, D: College of American Pathologists Gallup Study Findings on Colon Cancer. Radio Interview. College of American Pathologists, March 2005.
ff Whitney-Miller C and Sesok-Pizzini D.: Evaluation of platelet refractoriness at a large transfusion service. Archives of Pathology and Laboratory Medicine 129: 568-569, April 2005.
ac Sesok-Pizzini, D: Bike Helmet Safety. Radio Interview. College of American Pathologists, June 2005.
177 Sesok-Pizzini, DA: Approaches to Managing Quality and Patient Safety. Quality Management in Clinical Laboratories, Promoting Patient Safety Through Risk Reduction and Continuous Improvement. Paul Valenstein (eds.). College of American Pathologists, Page: 38-40, 2005 Notes: Contributing chapter author.
10c Sesok-Pizzini, D: Immunological Effects of ABO-Incompatible HPC Transplantation. Cellular Therapy: A Physician's Handbook. Hakey NR, Snyder EL, Triulzi D (eds.). AABB Press, Page: 180-185, 2004.
2c